Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Jul 22, 2026
TickeronGET DAILY SIGNALS
AMERISAFE (AMSF) Reports +11.4% Premium Growth in Q2

AMERISAFE (AMSF) Reports +11.4% Premium Growth in Q2

Key Takeaways

  • Net premiums earned rose 11.4% year-over-year to $269.7 million.
  • Net income reached $14.6 million, or $0.78 per share.
  • Operating net income was $8.3 million, or $0.44 per share.
  • Return on average equity stood at 11.4% for the quarter.
  • Results reflect continued expansion in high-hazard workers’ compensation lines.

Why These Results Matter

AMERISAFE, Inc. specializes in workers’ compensation insurance for high-hazard industries. Its quarterly results provide insight into underwriting trends, premium pricing power, and loss ratios in a niche market. Investors track these figures closely because sustained premium growth can signal expanding demand and pricing discipline, while any shifts in loss experience directly affect profitability and capital returns in the insurance sector.

Q2 Results Breakdown

For the second quarter ended June 30, 2026, AMERISAFE reported net premiums earned of $269.7 million, an 11.4% increase from the prior-year period. Net income totaled $14.6 million, or $0.78 per diluted share. Operating net income, which excludes certain investment gains and losses, came in at $8.3 million, or $0.44 per share. The company posted a return on average equity of 11.4%.

Compared with consensus expectations, the reported net income exceeded analyst forecasts, while the operating earnings figure aligned closely with projections. Premium growth outpaced recent quarters and contributed positively to top-line momentum. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

How the Market Responded

Shares of AMERISAFE traded higher in the sessions following the July 21 release, reflecting investor focus on the solid premium expansion. Market participants viewed the results as evidence of resilient demand in the company’s specialized insurance niche, with limited negative surprises on the underwriting side.

What to Watch Going Forward

Investors will watch for updates on loss ratios and claims frequency in high-hazard industries. Continued premium growth will depend on the company’s ability to maintain pricing discipline amid competitive pressures.

Management commentary on expense management and investment income trends will help clarify margin sustainability. Broader economic conditions affecting construction, manufacturing, and energy sectors could influence future policy renewals and loss experience.

Upcoming catalysts include any revisions to full-year guidance and details from the earnings conference call regarding reserve development and capital allocation plans. From what I see, these factors will be key to assessing whether the recent momentum holds.

Using AI Tools for Deeper Analysis

In my own review of the results, I turned to Tickeron’s AI Screener to quickly compare AMERISAFE’s metrics against peers in the insurance space. The tool allowed me to filter for similar companies based on premium trends, profitability, and technical signals, which helped put the quarter into better context without spending hours on manual research. It’s become a regular part of how I evaluate specialized insurers like this one.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AMSF

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


AMSF sees MACD Histogram crosses below signal line

AMSF saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 29, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In 27 of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 61%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMSF as a result. In 53 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.

AMSF moved below its 50-day moving average on October 29, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AMSF crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 45%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMSF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 58%.

The Aroon Indicator for AMSF entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMSF advanced for three days, in 166 of 294 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

AMSF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 43 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.453) is normal, around the industry mean (0.987). P/E Ratio (7.836) is within average values for comparable stocks, (11.360). AMSF's Projected Growth (PEG Ratio) (2.410) is slightly higher than the industry average of (0.944). Dividend Yield (0.084) settles around the average of (0.486) among similar stocks. P/S Ratio (1.394) is also within normal values, averaging (2.529).

The Tickeron SMR rating for this company is 49 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. AMSF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 91 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMSF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 57, placing this stock worse than average.

Industry description

Specialty insurance typically caters to niche-markets, and covers items that are special or unique and/or items that are not typically covered under other insurance policies. Restoration or purchase of a one-of-a-kind collector’s item, high-value home, recreational vehicles, sailboat or even jet skis, horses and farms, all-terrain vehicle, funerals, museums and fine art collections are some examples– one or more of which are covered by a specialty insurance provider. In some cases, a specialty insurance could also complement someone’s existing auto, home and umbrella policies. Markel Corp, for Fidelity National Financial, Inc., Assurant, Inc. and Athene Holding Ltd. are examples of specialty insurance providers.

Market Cap

The average market capitalization across the Specialty Insurance Industry is 3.84B. The market cap for tickers in the group ranges from 2.22M to 11.76B. FNF holds the highest valuation in this group at 11.76B. The lowest valued company is MMMM at 2.22M.

High and low price notable news

The average weekly price growth across all stocks in the Specialty Insurance Industry was -3%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was -6%. RDN experienced the highest price growth at 1%, while OSG experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Specialty Insurance Industry was -2%. For the same stocks of the Industry, the average monthly volume growth was -19% and the average quarterly volume growth was 35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 46
Price Growth Rating: 58
SMR Rating: 83
Profit Risk Rating: 57
Seasonality Score: 15 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of workers compensation insurance for businesses in hazardous industries

Industry SpecialtyInsurance

Industry
Life Or Health Insurance
Address
2301 Highway 190 West
Phone
+1 337 463-9052
Employees
370
Web
https://www.amerisafe.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.